The national hepatitis C elimination initiative would substantially reduce HCV-related morbidity and mortality and would reduce healthcare spending at 10 years and beyond.
USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.
The cumulative social benefits from Medicare coverage for new obesity treatments over the next 10 years would reach almost $1 trillion, or roughly $100 billion per year.
Given the serious health and financial ramifications of obesity, policymakers should consider the value of increased investment in obesity treatment efforts.
Applying artificial intelligence and machine learning to person-generated health data allows unprecedented assessment of associations between everyday life and health outcomes.
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
Nephrologists’ ownership of dialysis facilities doesn’t affect outcomes, but why is it so secret?
If saving lives is the objective, then logic, clinical evidence and compassion dictate that Medicare should pay for preventing and treating obesity, starting now.
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
The majority of diabetic patients do not receive adequate eye care within the 5 years after initial diabetes diagnosis despite having insurance.